Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Articaine hydrochloride and epinephrine

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Articaine hydrochloride and epinephrine used for?
The FDA-approved label (Articadent, Dentsply Pharmaceutical, March 1, 2024) says: “ARTICADENT is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age or older. ARTICADENT is a combination of articaine HCl, an amide local anesthetic, and epinephrine, a vasoconstrictor, is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Articaine hydrochloride and epinephrine have a boxed warning?
No. None of the 19 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Articaine hydrochloride and epinephrine?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Articaine hydrochloride and epinephrine been recalled?
FDA enforcement reports list 1 recall of products of this medicine; the newest started May 2, 2019 (Class II). A recall usually concerns specific lots, not every product.
Who makes Articaine hydrochloride and epinephrine?
11 companies list prescription products of Articaine hydrochloride and epinephrine in the FDA NDC Directory, including Novocol Pharmaceutical of Canada, Inc., Septodont, Inc. and Burkhart Dental Supply Co., Inc.

What Articaine hydrochloride and epinephrine is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

ARTICADENT is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age or older. ARTICADENT is a combination of articaine HCl, an amide local anesthetic, and epinephrine, a vasoconstrictor, is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric …

— FDA label: Articadent, Dentsply Pharmaceutical, effective March 1, 2024. Read the full label on DailyMed →

The FDA has 19 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 19 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsInjection, solution · Injection
RouteSubmucosal
Prescription products28 in the FDA NDC Directory
Brand namesArticadent, Septocaine and Epinephrine, Orabloc, Zorcaine

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA020971
SEPTOCAINE
DeprocoApril 3, 2000 17, latest November 2, 2018
2018: Labeling · 2017: Manufacturing (CMC) · 2016: Manufacturing (CMC)
NDA022466
ORABLOC
PierrelFebruary 26, 2010 4, latest July 2, 2025
2025: Labeling · 2018: Labeling · 2014: Manufacturing (CMC)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. May 2, 2019 · Class II · Terminated · D-1307-2019

    Labeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2% Xylocaine DENTAL and Articadent DENTAL. Xylocaine DENTAL is a trade name for Lidocaine HCL 2% and Epinephrine 1: 100,000 formulation, while Articadent D

    Articaine DENTAL, Articane hydrochloride 4% and epinephrine 1:100,000, 50 cartridges. 1.7 mL each, Rx only, Manufactured for: DENTSPLY Pharmaceutical, by Novocol Pharmaceutical of Canada, Inc. York, PA 17404, NDC 66312-6 — Septodont Inc.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Official identifiers

RxCUI (RxNorm)861588, 861592, 1011646, 1011648, 1091068, 1091072, 1150829, 1595029, 1595035, 1658966 … (+1)
SPL set ID of the quoted label9ca8fb43-4f34-47c0-8b79-3b5bd1eaee00
FDA labels (SPL)19
FDA applicationsNDA020971, NDA022466
Active ingredients (FDA)ARTICAINE / EPINEPHRINE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Articadent, Dentsply Pharmaceutical, effective March 1, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers